Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4447706 | 0.77 | TSHR (0.35) | KIF11FFAR3ALDH1A1TSHRCA2 | |
| SCHEMBL2097975 | 0.72 | FFAR3 (0.35) | KIF11FFAR3ALDH1A1TSHRCA2 | |
| SCHEMBL10951913 | 0.70 | ALDH1A1 (0.38) | KIF11FFAR3ALDH1A1TSHRCA2 | |
| SCHEMBL1562024 | 0.70 | TSHR (0.38) | KIF11FFAR3ALDH1A1TSHRCA2 | |
| SCHEMBL8689396 | 0.70 | TSHR (0.38) | FFAR3ALDH1A1TSHRCA2MAPK1 | |
| SCHEMBL31430102 | 0.69 | SLC22A6 (0.31) | ALDH1A1 | |
| SCHEMBL10926065 | 0.69 | THRB (0.32) | ALDH1A1 | |
| SCHEMBL3061236 | 0.68 | ALDH1A1 (0.32) | FFAR3ALDH1A1TSHRCA2MAPK1 | |
| SCHEMBL8725998 | 0.68 | ALDH1A1 (0.32) | FFAR3ALDH1A1TSHRCA2MAPK1 | |
| SCHEMBL11426151 | 0.68 | ALDH1A1 (0.36) | FFAR3ALDH1A1TSHRCA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4045544-B1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-12534561-B2 | Controlled radical polymerization | BASF COATINGS GMBH (DE) | 2026-01-27 | — | — | US | disclosed |
| US-12497712-B2 | Property modulation with chemical transformations | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-12-16 | — | — | US | disclosed |
| US-20240294689-A1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| CN-117321088-A | Preparation of monodisperse Polymer beads by Room temperature initiation | 深圳华大基因科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| EP-4045544-A1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF Coatings GmbH (DE) | 2022-08-24 | — | — | EP | disclosed |
| EP-3973534-A1 | PROPERTY MODULATION WITH CHEMICAL TRANSFORMATIONS | The Regents Of The University Of Michigan (US) | 2022-03-30 | — | — | EP | disclosed |
| WO-2021074001-A1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2021-04-22 | — | — | WO | disclosed |
| US-20200370204-A1 | PROPERTY MODULATION WITH CHEMICAL TRANSFORMATIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2020-11-26 | — | — | US | disclosed |
| EP-2316459-B1 | 2,4-pyrimidinediamine compounds for use in methods of treating or preventing autoimmune diseases | RIGEL PHARMACEUTICALS INC (US) | 2013-11-06 | — | — | EP | disclosed |
| WO-2000012567-A1 | THERMOSETTING COMPOSITIONS CONTAINING HYDROXYL-FUNCTIONAL POLYMERS PREPARED USING ATOM TRANSFER RADICAL POLYMERIZATION | PPG INDUSTRIES OHIO, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012636-A1 | ELECTRODEPOSITABLE COATING COMPOSITIONS COMPRISING ONIUM SALT GROUP-CONTAINING POLYMERS PREPARED BY ATOM TRANSFER RADICAL POLYMERIZATION | PPG INDUSTRIES OHIO, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012580-A1 | THERMOSETTING COMPOSITIONS CONTAINING EPOXY-FUNCTIONAL POLYMERS PREPARED USING ATOM TRANSFER RADICAL POLYMERIZATION | PPG INDUSTRIES OHIO, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012581-A1 | THERMOSETTING COMPOSITIONS CONTAINING EPOXY FUNCTIONAL POLYMERS PREPARED BY ATOM TRANSFER RADICAL POLYMERIZATION | PPG INDUSTRIES OHIO, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| US-5824652-A | IMMUNOSTIMULANTS, ANTITUMOR AGENTS | UNIVERZA V LJUBLJANI, FAKULTETA ZA NARAVOSLOVJE IN TECHNOLOGIJO, ODDELEK ZA FARMACIJO (SI) | 1998-10-20 | — | — | US | disclosed |
| EP-0695308-B1 | NOVEL HETEROCYCLIC ACYLDIPEPTIDES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | UNIV LJUBLJANI (SI) | 1998-07-01 | — | — | EP | disclosed |
| EP-0695308-A1 | NOVEL HETEROCYCLIC ACYLDIPEPTIDES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | UNIVERZA V LJUBLJANI, FAKULTETA ZA NARAVOSLOVJE IN TEHNOLOGIJO, ODDELEK ZA FARMACIJO (SI) | 1996-02-07 | — | — | EP | disclosed |
| WO-1994024152-A1 | NOVEL HETEROCYCLIC ACYLDIPEPTIDES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | UNIVERZA V LJUBLJANI, FAKULTETA ZA NARAVOSLOVJE IN TEHNOLOGIJO, ODDELEK ZA FARMACIJO (SI) | 1994-10-27 | — | — | WO | disclosed |
| US-4228300-A | Polycarboxylate ethers | MONSANTO COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| US-4013714-A | SUBSTITUTED BIS-(DICARBOXYMETHYL)-ETHERS | MONSANTO COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534561-B2 | Controlled radical polymerization | TST, G6PD, PROC | KIF11 2761/4885FFAR3 2189/4885ALDH1A1 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.